Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | 84.88% | 243.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 84.88% | 243.61% |
| Operating Income | -- | -- | -- | -84.88% | -243.61% |
| Income Before Tax | -- | -- | -- | -530.66% | -237.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -530.66% | -237.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -530.66% | -237.22% |
| EBIT | -- | -- | -- | -84.88% | -243.61% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -333.77% | -217.48% |
| Normalized Basic EPS | -- | -- | -- | -34.38% | -217.71% |
| EPS Diluted | -- | -- | -- | -333.77% | -217.48% |
| Normalized Diluted EPS | -- | -- | -- | -34.38% | -217.71% |
| Average Basic Shares Outstanding | -- | -- | -- | 31.94% | 65.78% |
| Average Diluted Shares Outstanding | -- | -- | -- | 31.94% | 65.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
